Buy or sell Avadim Technologies stock pre IPO via an EquityZen fund
Avadim Technologies Stock
Avadim Technologies Inc is a life sciences company.
About Avadim Technologies Stock
Avadim Technologies Inc is a life sciences company that has developed a new class of life sciences solutions based on Pathogenesis Based Therapies (“PBTs”) which work to optimize the stratum corneum, integumentary functions and the associated reactive tissue. Their platform of therapies works to protect and support natural physiological functions of the outer barrier of the body, to super normalize it, supporting treatments within their three series of therapies for infection prevention, neuromuscular disorders and barrier repair. Their platform and technologies use a targeted topical delivery system, are non-toxic and are effective without the side effects of other remedy approaches. Initial acceptance in the U.S. clinical market of their first PBTs and their novel preventative approach, have shown both cost avoidance and superior effectiveness in addressing specific needs in healthcare. Avadim’s advanced therapeutic class of Pathogenesis Based Therapies is capable of unlocking pathways to address emerging gaps in global health.